# Homocysteine Study (HOST)

> **NCT00032435** · PHASE3 · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 2003 (estimated)

## Conditions studied

- End Stage Renal Disease
- Renal Failure

## Interventions

- **DRUG:** PAL-40 Active
- **DRUG:** PAL-40 Placebo

## Key facts

- **NCT ID:** NCT00032435
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2006-08
- **Final completion:** 2006-09
- **Target enrollment:** 2003 (ESTIMATED)
- **Last updated:** 2010-10-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00032435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00032435, "Homocysteine Study (HOST)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00032435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*